Monoclonal Antibody DL11C8 Identifies ADAM23 as a Component of Lipid Raft Microdomains
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 384, 165-177
Abstract
No abstract availableKeywords
Funding Information
- CNPq (465682/2014-6, 401591/2014-0, 467566/2014-3, 405672/2016-0)
- Fundação Araucária
- FINEP
- CAPES
- PRONEX
This publication has 47 references indexed in Scilit:
- Leucine-rich glioma inactivated 3 regulates adipogenesis through ADAM23Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Substrate-Immobilized HIV-1 Tat Drives VEGFR2/α v β 3 –Integrin Complex Formation and Polarization in Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Identification of a Novel Idiopathic Epilepsy Locus in Belgian Shepherd DogsPLOS ONE, 2012
- Plasma membrane microdomains regulate TACE‐dependent TNFR1 shedding in human endothelial cellsJournal of Cellular and Molecular Medicine, 2011
- The expression of ADAM23 and its correlation with promoter methylation in non‐small‐cell lung carcinomaInternational Journal of Experimental Pathology, 2011
- LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphologyMolecular and Cellular Neuroscience, 2009
- ADAM23 Negatively Modulates αvβ3 Integrin Activation during MetastasisCancer Research, 2009
- Regulation of the proteolytic disintegrin metalloproteinases, the ‘Sheddases’Seminars in Cell & Developmental Biology, 2009
- ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylationOncogene, 2005
- ADAM23 methylation and expression analysis in brain tumorsNeuroscience Letters, 2005